MedPath

Effects of Naloxane on Pain Control in Post operative Management of Hysterectomy Surgery

Not Applicable
Conditions
Pain.
acute pain
Registration Number
IRCT201012025175N4
Lead Sponsor
Tehran University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

1-ASA physical status I and II
scheduled for total abdominal hysterectomy with standadized general aneshteshia/
2-Age between 35-65 years old
Exclusion criteria :
1-Hepatic or Renal failure, Heart diseases,
2- history of drug allergy, substance abuse (including opioids and benzodiazepines) ,
3-morbid obesity,
4-history of postoperative nausea and vomiting(PONV),history of motion sickness
5- smokers

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Morphine Consumption. Timepoint: 0 ,30 min,1hr, 2hr, 4hr, 8hr, 16hr, 20hr, 24hr after surgery. Method of measurement: Opioid registration by milligrams.;Pain Intensity. Timepoint: 0 ,30 min,1hr, 2hr, 4hr, 8hr, 16hr, 20hr, 24hr after surgery. Method of measurement: NRS( Numeric Rating Score).
Secondary Outcome Measures
NameTimeMethod
Duration of operation. Timepoint: during the operation. Method of measurement: operating chart.;Intraoperative Fluid received. Timepoint: during the operation. Method of measurement: Crystaloid Fluid registration chart.;Pruritus. Timepoint: 0 ,30 min,1hr, 2hr, 4hr, 8hr, 16hr, 20hr, 24hr after surgery. Method of measurement: Numeric Rating score (NRS).;Post operative Nausea and Vomiting. Timepoint: 0 ,30 min,1hr, 2hr, 4hr, 8hr, 16hr, 20hr, 24hr after surgery. Method of measurement: NRS (Numeric Rating score).
© Copyright 2025. All Rights Reserved by MedPath